In vitro susceptibility of Candida spp. isolated from clinical specimens against some antifungal agents
Turkish Journal of Pharmaceutical Sciences, cilt.3, sa.1, ss.1-6, 2006 (Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 3 Sayı: 1
- Basım Tarihi: 2006
- Dergi Adı: Turkish Journal of Pharmaceutical Sciences
- Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.1-6
- Anahtar Kelimeler: Antifungal susceptibility, Candida spp., In vitro activity
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
We evaluated the in vitro activity of ketoconazole (KET), fluconazole (FLU), itraconazole (ITRA), amphotericin B (AmpB), flucytosine (FCU) in comparison to voriconazole (VOR) against Candida species isolated from blood cultures. The most common species of identified Candida were C. albicans (71), followed by C. parapsilosis (16), C. glabrata (12) C. tropicalis (9), C. kefyr (8) and one of C. lustaniae, C. spherical, C. sake, C. lambria respectively. NCCLS M 27-A method was used to evaluate the activity of KET, FLU, ITRA, AmpB, FCU and VOR. The MICs of the strains were evaluated by RPMI 1640 medium with microdilution method. There were no isolates of tested Candida spp. resistant to KET, ITRA, FCU, AmpB and VOR. Only two of C. albicans isolates were resistant to FLU (MIC; ≥32μg/ml). Intermediate resistant appeared in 17.5% isolates to KET and FLU, 8.3% isolates to ITRA. Among 120 Candida isolates were found highly susceptible to KET (MIC;≤8μg/ml) followed by VOR (MIC;≤0.03μg/ml), ITRA (MIC;≤0.125μg/ml) FCU (MIC;≤4μg/ml) AmpB (MIC;<1μg/ml), and FLU (MIC; ≤8μg/ml) so FCU, AmpB and VOR were each more active than KET, FLU, and ITRA.